{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:07:11Z","timestamp":1790816831714,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.taap.2026.118045","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:29:16Z","timestamp":1789860556000},"page":"118045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reprogramming NAD+ homeostasis and FOXO3a\u2013Nrf2 signaling mitigates bleomycin-driven pulmonary fibrosis"],"prefix":"10.1016","volume":"516","author":[{"given":"Maha","family":"Mo'men","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan A.","family":"El-Kashef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.118045_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114553","article-title":"Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model","volume":"161","author":"Abdelhady","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2026.118045_bb0010","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2026.118045_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/20565623.2025.2483607","article-title":"The multifaceted effects of semaglutide: exploring its broad therapeutic applications","volume":"11","author":"Alkhatib","year":"2025","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.taap.2026.118045_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104642","article-title":"Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats","volume":"93","author":"Aran\u00e4s","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.taap.2026.118045_bb0025","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1164\/ajrccm.163.7.2006132","article-title":"Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis","volume":"163","author":"Borzone","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.taap.2026.118045_bb0030","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1124\/pr.110.003905","article-title":"Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?","volume":"64","author":"Cant\u00f3","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2026.118045_bb0035","doi-asserted-by":"crossref","first-page":"F106","DOI":"10.1152\/ajprenal.00126.2009","article-title":"Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure","volume":"297","author":"Cho","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.taap.2026.118045_bb0040","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0259-2024","article-title":"A new era in the treatment of progressive fibrosing interstitial lung diseases","volume":"21","author":"Denis","year":"2025","journal-title":"Breathe"},{"key":"10.1016\/j.taap.2026.118045_bb0045","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3892\/ijmm.2016.2503","article-title":"SIRT1 exerts protective effects against paraquat-induced injury in mouse type II alveolar epithelial cells by deacetylating NRF2 in vitro","volume":"37","author":"Ding","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.taap.2026.118045_bb0050","article-title":"Activation of AMPK\/SIRT1\/FOXO3a signaling by BMS-477118 (saxagliptin) mitigates chronic colitis in rats: uncovering new anti-inflammatory and antifibrotic roles","volume":"15-2024","author":"Elmorsy","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.118045_bb0055","article-title":"E1231\/NMN protects against experimental metabolic syndrome: the central role of SIRT1 in modulating AKT\/Nrf2\/NF\u03baB signaling","volume":"16-2025","author":"Elmorsy","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.118045_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107002","article-title":"Activation of SIRT1 by SRT1720 alleviates dyslipidemia, improves insulin sensitivity and exhibits liver-protective effects in diabetic rats on a high-fat diet: new insights into the SIRT1\/Nrf2\/NF\u03baB signaling pathway","volume":"206","author":"Elmorsy","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.taap.2026.118045_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107302","article-title":"Activation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD+\/SIRT1\/PGC-1\u03b1 signaling pathway and modulation of NF\u03baB\/TNF-\u03b1\/IL-6","volume":"214","author":"Elmorsy","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.taap.2026.118045_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74912-1","article-title":"GLP-1 receptor agonist ameliorates experimental lung fibrosis","volume":"10","author":"Fandi\u00f1o","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2026.118045_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1949718","article-title":"Natural compounds for SIRT1-mediated oxidative stress and neuroinflammation in stroke: a potential therapeutic target in the future","volume":"2022","author":"Fang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.taap.2026.118045_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2023.07.1984","article-title":"Combination therapy with pirfenidone and nintedanib in idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"164","author":"Gandhi","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.taap.2026.118045_bb0085","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.nano.2017.04.005","article-title":"Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s)","volume":"13","author":"Garbuzenko","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.taap.2026.118045_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.550955","article-title":"Hyperoside attenuates bleomycin-induced pulmonary fibrosis development in mice","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.118045_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043149","article-title":"Immune mechanisms of pulmonary fibrosis with bleomycin","volume":"24","author":"Ishida","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.taap.2026.118045_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157570","article-title":"Pexidartinib and nintedanib combination therapy targets macrophage polarization to reverse pulmonary fibrosis: a preclinical study","volume":"26","author":"Kim","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.118045_bb0105","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2026.118045_bb0110","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-010-2028-x","article-title":"Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes","volume":"54","author":"Kodera","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.taap.2026.118045_bb0115","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01105-2019","article-title":"The importance of interventional timing in the bleomycin model of pulmonary fibrosis","volume":"55","author":"Kolb","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.taap.2026.118045_bb0120","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2147\/DDDT.S484531","article-title":"Semaglutide alleviates ovary inflammation via the AMPK\/SIRT1\/NF-\u03baB signaling pathway in polycystic ovary syndrome mice","volume":"18","author":"Liu","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.taap.2026.118045_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116282","article-title":"Comprehensive review of potential drugs with anti-pulmonary fibrosis properties","volume":"173","author":"Ma","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2026.118045_bb0130","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/1440-1681.13378","article-title":"Modulation of bleomycin-induced oxidative stress and pulmonary fibrosis by N-acetylcysteine in rats via AMPK\/SIRT1\/NF-\u03ba\u03b2","volume":"47","author":"Mansour","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.taap.2026.118045_bb0135","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1007\/s00210-024-03687-3","article-title":"Neuroprotective effect of niacin in a rat model of obesity induced by high-fat-rich diet","volume":"398","author":"Manzoor","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.taap.2026.118045_bb0140","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","article-title":"The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?","volume":"40","author":"Moeller","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.taap.2026.118045_bb0145","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/ph16081123","article-title":"Alvespimycin exhibits potential anti-TGF-\u03b2 signaling in the setting of a proteasome activator in rats with bleomycin-induced pulmonary fibrosis: a promising novel approach","author":"Mohammed","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.taap.2026.118045_bb0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-020-00354-w","article-title":"NAD+ metabolism, stemness, the immune response, and cancer","volume":"6","author":"Navas","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.taap.2026.118045_bb0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.21037\/jtd.2018.11.131","article-title":"Adjunctive therapies in idiopathic pulmonary fibrosis\u2014where do we stand?","volume":"11","author":"Nokes","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.taap.2026.118045_bb0160","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s43587-024-00758-1","article-title":"Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial","volume":"4","author":"Norheim","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.taap.2026.118045_bb0165","article-title":"Oxidative stress and inflammation regulation of sirtuins: new insights into common oral diseases","volume":"13-2022","author":"Pan","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.taap.2026.118045_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ph17020226","article-title":"The role of NAD(+) and NAD(+)-boosting therapies in inflammatory response by IL-13","volume":"17","author":"Pugel","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.taap.2026.118045_bb0175","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/biom15101403","article-title":"GLP-1 receptor agonists in heart failure","author":"Rahmani","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.taap.2026.118045_bb0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s11658-019-0158-9","article-title":"The role of different SIRT1-mediated signaling pathways in toxic injury","volume":"24","author":"Ren","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.taap.2026.118045_bb0185","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2026.118045_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112731","article-title":"Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-\u03baB signaling: a new challenge for unmet therapeutic needs","volume":"148","author":"Saber","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2026.118045_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107099","article-title":"E1231\/SR647 protects against unilateral renal ischemia-reperfusion injury by modulating SIRT1\/FOXO3 interactions with Nrf2 and NF\u03baB pathways","volume":"209","author":"Saber","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.taap.2026.118045_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48566-8","article-title":"Protective effects of niacin following high fat rich diet: an in-vivo and in-silico study","volume":"13","author":"Samad","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2026.118045_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101902","article-title":"Targeting CD38-dependent NAD(+) metabolism to mitigate multiple organ fibrosis","volume":"24","author":"Shi","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.taap.2026.118045_bb0210","article-title":"Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function","volume":"12-2024","author":"Su","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.taap.2026.118045_bb0215","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jaci.2017.11.043","article-title":"Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo","volume":"142","author":"Toki","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.taap.2026.118045_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115285","article-title":"Niacin modulates SIRT1-driven signaling to counteract radiation-induced neurocognitive and behavioral impairments","volume":"26","author":"Tun\u00e7","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.118045_bb0225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12929-019-0496-y","article-title":"Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension","volume":"26","author":"Wang","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.taap.2026.118045_bb0230","first-page":"1685","article-title":"The role of Nrf2 in pulmonary fibrosis: molecular mechanisms and treatment approaches","author":"Wang","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.taap.2026.118045_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109716","article-title":"Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R\/SIRT1\/GLUT4 pathway","volume":"240","author":"Wang","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2026.118045_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.744","article-title":"Pulmonary fibrosis: pathogenesis and therapeutic strategies","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.taap.2026.118045_bb0245","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00022-2025","article-title":"Integrated spatial and single-cell transcriptomics reveal PAK kinase as a therapeutic target in fibroblastic foci and dense fibrosis of idiopathic pulmonary fibrosis","volume":"66","author":"Watanabe","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.taap.2026.118045_bb0250","series-title":"Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver Disorders","author":"Weiskirchen","year":"2025"},{"key":"10.1016\/j.taap.2026.118045_bb0255","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2147\/DMSO.S451129","article-title":"Effects of glucagon-like peptide-1 receptor agonists on gut microbiota in dehydroepiandrosterone-induced polycystic ovary syndrome mice: compared evaluation of liraglutide and semaglutide intervention","volume":"17","author":"Xiong","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.taap.2026.118045_bb0260","article-title":"SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-\u03baB activity","volume":"7","author":"Yang","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.taap.2026.118045_bb0265","article-title":"Regulation of SIRT1 and its roles in inflammation","volume":"13-2022","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.taap.2026.118045_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108906","article-title":"Exploring the antioxidant properties of semaglutide: a comprehensive review","volume":"38","author":"Yaribeygi","year":"2024","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.taap.2026.118045_bb0275","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","article-title":"Modulation of NF-\u03baB-dependent transcription and cell survival by the SIRT1 deacetylase","volume":"23","author":"Yeung","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.taap.2026.118045_bb0280","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s40200-025-01663-z","article-title":"The expanding role of semaglutide: beyond glycemic control","volume":"24","author":"Zarei","year":"2025","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.taap.2026.118045_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2025.106987","article-title":"GLP-1RAs regulate lipid metabolism and induce autophagy through AMPK\/SIRT1 pathway to improve NAFLD","volume":"178","author":"Zhang","year":"2025","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.taap.2026.118045_bb0290","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"220","key":"10.1016\/j.taap.2026.118045_bb0295","doi-asserted-by":"crossref","DOI":"10.3791\/68484","article-title":"Refined murine model of idiopathic pulmonary fibrosis","author":"Zhu","year":"2025","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.taap.2026.118045_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112723","article-title":"Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-\u03baB and NLRP3 crosstalk: a novel approach for filling an unmet medical need","volume":"148","author":"Zohny","year":"2022","journal-title":"Biomed. Pharmacother."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26003418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26003418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:47:47Z","timestamp":1790815667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26003418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":60,"alternative-id":["S0041008X26003418"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.118045","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming NAD+ homeostasis and FOXO3a\u2013Nrf2 signaling mitigates bleomycin-driven pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.118045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118045"}}